Podcast
MSL Talk: Tom Caravela, Kent Christofferson
Repackage what you have for what you want
Summary
In this episode, Cherie Hyder shares her journey from the FDA to the industry, discussing the transition and how to enhance skills for a successful MSL career. She emphasizes the importance of documenting experience and understanding the MSL role, highlighting the MSL capability continuum and certification programs. Cherie discusses the significance of soft skills and digital proficiency, along with predictions for the post-pandemic MSL landscape. She offers insights into effective email communication, evolving metrics, and the critical role of insight gathering. The episode wraps up with best practices for post-meeting note-taking and career development strategies.
Check out my latest podcast with Cherie Hyder, Medical Excellence at Biohaven who discusses how to repackage what you have for what you want.
Cherie shares….
How to position yourself for MSL roles
Tool and resources to be aware of
How to showcase important skills and traits
Certification programs and if they are worth it
Mandatory skills for the MSL of the future
MSL career transition, MSL capability continuum, post-pandemic MSL landscape, MSL digital proficiency, MSL certification programs
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Kent Christofferson
Podcast
MSL Talk: Tom Caravela, Amanda Vaughn
Landing My First MSL Role: From the Inside
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO